Dermatology Times, December 2018 (Vol. 39, No. 12)

European data protection regulation impacts U.S. patient privacy

December 13, 2018

European Union regulation on data protecion has put pressure on U.S. legislators and regulators to heighten protections within our own borders, experts say. The ramifications for healthcare organizations, both abroad and in the United States, are significant. Here’s what you need to know.

Proscia to expand its artificial intelligence software line

December 08, 2018

Proscia Inc., a digital technology company specializing in the development of artificial intelligence applications and software for digital pathology, recently secured $8.3 million in an initial round of financing.

Advances in atopic dermatitis raise bar for treatment

December 07, 2018

In this article, Dr. Peter A. Lio discusses how recent advances in atopic dermatitis have led to a new standard of care, which aims to keep patients clear safely and maximize improvements in quality of life.

Differences in opioid prescribing practices

December 06, 2018

When it comes to opioids, neither patient nor provider is equal. This article explores recent research that highlights the differences in who will receive and who will write a prescription for opioids.

Four effective anti-IL 23 drugs for psoriasis

October 17, 2018

Two approved and two pending anti-IL 23 drugs offer an opportunity for moderate to severe psoriasis patients to regain their lives, according to researchers presenting at the 2018 Fall Clinical Dermatology Conference.

Surgeons defer procedures during early stage pregnancy

October 16, 2018

Prompt management of skin cancer lesions is stressed for pregnant patients in a recent article in the Journal of the American Academy of Dermatology, but whether it’s applied in clinical practice is unknown.

Mortality high in squamous cell carcinoma in hidradenitis suppurativa

October 15, 2018

Squamous cell carcinoma in hidradenitis suppurativa is rare, but mortality is high, according to Mayo Clinic researchers reporting at the American Society for Dermatologic Surgery annual meeting last week in Phoenix.

PET-CTs for melanoma may have less benefit than previously thought

October 15, 2018

Stage II melanoma patients don’t always benefit from staging PET-CT, according to Duke University Medical Center researchers reporting last week at American Society of Dermatologic Surgery annual meeting in Phoenix.

A review of treatment for dermatofibrosarcoma

September 17, 2018

Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.

Individualized biologic therapy

July 11, 2018

A new study advises selecting biologic therapies for psoriasis based on individual factors such as patients' comorbidities, preferences and clinical situation, as well as the advantages and disadvantages of particular biologic treatments.